Clinical Trial Update: Investigate Safety, Tolerability, PK/PK of J2H 1702 in Healthy Males [Phase 1]

View source ↗

Summary

This document reports the completion of a Phase 1 trial evaluating the safety, tolerability, and pharmacokinetics of J2H 1702 in healthy male volunteers.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-alcoholic Steatohepatitis

Drugs mentioned

• J2H-1702 (J2H-1702)

Snippet

Sponsor: J2H Biotech | Conditions: Non-alcoholic Steatohepatitis | Phase 1 | Status: COMPLETED